ArticleBMC medicine2024

A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer.

Hanqiao Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.